We found that critically ill COVID-19 had a causal association with an increased risk of HER2-positive breast cancer, indicating individuals genetically predisposed to severe manifestations of COVID-19 potentially carry a higher risk of developing HER2-positive breast cancer. The gene discussed is ERBB2; the disease is COVID-19.